Hummingbird CEO and Co-Founder Piers Ingram speaks to PharmaBoardroom in exclusive interview
27 May, 2021
Hummingbird discusses why cutting-edge digital tools and data-rich computational approaches play a powerful role in the development of precision biotherapeutics.
